GeneXpert MTB/RIF System

GeneXpert MTB/RIF System: Complete Guide to TB Detection in Children | PediaDevices

At a Glance

  • Device type: Cartridge-based, automated real-time PCR system
  • Made by: Cepheid (USA)
  • What it detects: Mycobacterium tuberculosis (MTB) DNA + rifampicin resistance
  • Result time: Approximately 90 minutes
  • Primary specimen (children): Sputum, gastric aspirate, induced sputum, BAL, stool (Ultra version)
  • WHO endorsed: Yes - recommended as a first-line TB diagnostic test

What Is the GeneXpert MTB/RIF System?

Tuberculosis (TB) is one of the leading infectious diseases affecting children worldwide. Diagnosing TB in children has always been a challenge because children with TB often have very few bacteria in their body, making traditional tests unreliable. The GeneXpert MTB/RIF System, also called the Xpert MTB/RIF assay, is a molecular diagnostic device that changed this situation.

Developed by Cepheid, the GeneXpert system uses a technology called real-time polymerase chain reaction (PCR) to detect the DNA of the tuberculosis bacterium (Mycobacterium tuberculosis) directly from a patient sample. At the same time, it checks whether the bacteria is resistant to rifampicin, which is one of the most important TB medicines. All of this happens inside a single-use plastic cartridge, in approximately 90 minutes, with very little manual work involved.

In 2010, the World Health Organization (WHO) recommended this test for TB diagnosis globally. It has since become a cornerstone of TB control programs in more than 130 countries, and its newer version, the GeneXpert MTB/RIF Ultra, is now especially recommended for children, where detecting small amounts of TB DNA is critical.

Why is this important for children? Children with TB usually have far fewer TB bacteria in their body than adults. This makes sputum smear microscopy - the older, traditional test - unreliable in this age group. The GeneXpert system is sensitive enough to detect even very small amounts of TB DNA, making it a much better choice for pediatric TB diagnosis.

Purpose and Where the Device Is Used

Main Purpose

The GeneXpert MTB/RIF system serves two major functions at the same time:

  • Detection of TB: It finds the genetic material (DNA) of Mycobacterium tuberculosis in a patient sample, confirming whether TB infection is present.
  • Drug resistance detection: It identifies mutations in the rpoB gene of the TB bacterium, which indicate resistance to rifampicin. Rifampicin resistance is a strong marker for multi-drug resistant TB (MDR-TB), because in most cases, resistance to rifampicin goes along with resistance to isoniazid, another core TB drug.

Where It Is Installed and Used

Setting Use
District and referral hospitals Primary diagnosis of pulmonary and extrapulmonary TB
Pediatric departments TB testing using gastric aspirate, induced sputum, BAL
TB clinics and chest units Routine diagnosis and drug resistance screening
HIV clinics TB co-infection diagnosis in HIV-positive individuals
Remote and field settings (GeneXpert Omni) Point-of-care testing where lab infrastructure is limited
National TB programs Population-level TB surveillance and control

Specimens Accepted

In adults, sputum is the standard specimen. In children, who often cannot produce sputum on their own, other specimens are used:

  • Induced sputum (sputum triggered by inhaling a saline mist)
  • Gastric aspirate (stomach fluid collected in the early morning)
  • Bronchoalveolar lavage (BAL) from the lungs
  • Cerebrospinal fluid (CSF) - for TB meningitis
  • Lymph node aspirates or tissue biopsies
  • Pleural fluid
  • Stool samples (Ultra version only, especially useful in young children)
Compared to older methods Traditional sputum smear microscopy takes minutes but misses many cases, especially in children. Mycobacterial culture, the gold standard, takes 2 to 6 weeks. GeneXpert delivers results in under 2 hours, allowing treatment to start without dangerous delays.

Types and Models Available

The GeneXpert platform is a modular system. Different instrument sizes are available depending on how many tests need to be done at a time. The cartridges used are the same across most platforms.

Cartridge (Assay) Types

Cartridge Key Feature Best Use
Xpert MTB/RIF Original assay; detects MTB and rifampicin resistance General TB diagnosis
Xpert MTB/RIF Ultra Higher sensitivity; detects lower amounts of TB DNA; reports "trace" results Children, HIV patients, extrapulmonary TB
About Xpert MTB/RIF Ultra in children The Ultra version is especially valuable in pediatric TB. Children with TB typically have very few bacteria (paucibacillary disease), and Ultra can detect even trace amounts of TB DNA. WHO recommends that "trace call" results in children should be treated as positive for clinical decisions.

Instrument Models (by number of modules)

Instrument Modules Tests per 8-hour day Typical Setting
GeneXpert I 1 Up to 4 Small clinics, low throughput
GeneXpert II 2 Up to 8 Primary health centers
GeneXpert IV 4 Up to 16 District hospitals
GeneXpert XVI 16 Up to 64 Referral hospitals
GeneXpert 48 / 80 48 or 80 High volume National reference labs
GeneXpert Omni 1 (battery-powered) Low volume Remote/field settings, no stable power

Each module in the instrument works independently. This means a 4-module machine can run 4 different patient tests at the same time, each potentially starting at a different time, without one affecting another.

How the GeneXpert MTB/RIF System Works

Understanding the science behind this device helps in appreciating why it is so reliable.

The Technology: PCR in a Cartridge

The Xpert MTB/RIF test uses a method called hemi-nested real-time PCR. PCR (polymerase chain reaction) is a technique that makes millions of copies of a specific piece of DNA so it can be detected easily. Here is what happens inside each cartridge:

  1. Sample enters the cartridge The patient's sputum (or other specimen) is mixed with a special sample reagent (containing sodium hydroxide and isopropanol) and transferred into the multi-chambered plastic cartridge. This reagent also kills the TB bacteria, making the sample safer to handle.
  2. Bacteria are captured and broken open Inside the cartridge, the TB bacteria are filtered out and concentrated. They are then broken open using a process called sonication (high-frequency sound waves), releasing their DNA.
  3. DNA amplification (PCR) The machine amplifies (copies) a specific part of the TB bacterium's DNA - the rpoB gene region - millions of times so it becomes detectable.
  4. Detection using molecular beacons Special fluorescent probes called molecular beacons bind to the copied DNA. Five overlapping probes (labeled A, B, C, D, and E) scan the rpoB gene for any mutations that signal rifampicin resistance.
  5. Automated result generation The machine's software reads the fluorescent signals and generates the final result automatically. The entire process takes approximately 90 minutes. No manual steps are needed after loading the cartridge.

Because all steps happen inside the sealed cartridge, there is almost no risk of sample contamination or laboratory exposure to live TB bacteria.

Step-by-Step User Guide

The following outlines the standard procedure for running the GeneXpert MTB/RIF test. Actual steps may vary slightly depending on the specific instrument model and institutional protocol. This guide follows general manufacturer and WHO-aligned recommendations.

Equipment and Materials Needed

  • GeneXpert instrument (connected to a power supply and computer with GeneXpert software)
  • Xpert MTB/RIF or Ultra cartridge (single-use, stored at 2-28 degrees C)
  • Sample reagent (SR) - provided with the cartridge kit
  • Patient specimen (sputum, gastric aspirate, BAL, etc.)
  • Transfer pipette or dropper
  • Gloves, lab coat, and appropriate PPE
  • Biohazard waste bag

Before Starting: Check These Points

Pre-test checks
  • Confirm the cartridge is within its expiry date
  • Let the cartridge reach room temperature (15-30 degrees C) before use if stored refrigerated
  • Confirm the instrument has been calibrated (yearly calibration required)
  • Ensure uninterrupted power supply is available
  • Check that the GeneXpert software is open and running on the connected computer

Step-by-Step Procedure

  1. Prepare the specimen For raw sputum: add sample reagent (SR) to the specimen in a 2:1 ratio (2 parts SR to 1 part sputum). Close the tube and mix by inverting 10 times. Let it sit at room temperature for 15 minutes, then mix again 10 times before use. For induced sputum or other specimen types, follow the specific preparation protocol for that specimen.
  2. Open the cartridge Peel back the cartridge label or open the cartridge lid. Do not touch the cartridge's internal components.
  3. Transfer the prepared sample Using the transfer pipette, fill the cartridge with the treated specimen to the "fill line" marked on the cartridge. Close the cartridge lid firmly until it clicks.
  4. Register the test in the software On the connected computer, open the GeneXpert software, create a new test entry, and enter the patient sample ID and test type. Select the module (numbered slot) where the cartridge will be placed.
  5. Load the cartridge into the instrument Open the GeneXpert instrument's module door. Insert the loaded cartridge into the module, label side facing outward. Close the module door. Start the test must begin within 4 hours of adding the sample reagent to the specimen.
  6. Start the test In the software, confirm the module assignment and click "Start Test." The instrument will run all remaining steps automatically. No further manual steps are needed.
  7. Wait for results The test runs for approximately 90 minutes. The software will notify when the result is ready. Do not open the module door during the run.
  8. Read and record the result The result will appear on the computer screen. Print or record the result as per institutional protocol. Remove the used cartridge with gloves and dispose of it in a biohazard waste container. Used cartridges should be treated as potentially infectious waste.

Understanding the Results

The GeneXpert system produces clearly labelled results. Here is what each result means:

Result Meaning Next Step
MTB NOT DETECTED No TB DNA found in the sample. TB is unlikely but not completely ruled out, especially in children with very low bacterial load. Consider repeat testing or culture if clinical suspicion remains high
MTB DETECTED - RIF Susceptible TB is present. No rifampicin resistance found. Standard first-line TB treatment is appropriate. Start standard treatment; confirm with culture if needed
MTB DETECTED - RIF Resistant TB is present AND rifampicin resistance detected. This is likely MDR-TB. Refer for specialized MDR-TB management; do full drug susceptibility testing
MTB DETECTED - RIF Indeterminate TB present, but rifampicin resistance status is unclear. Repeat testing; send for phenotypic drug susceptibility testing
ERROR / INVALID / NO RESULT The test did not run correctly. This may be due to cartridge issues, instrument error, or inhibitors in the sample. Repeat test with a new cartridge and fresh sample if possible
TRACE (Ultra version only) Very small amount of TB DNA detected, near the detection limit. In children, HIV patients, and extrapulmonary specimens: treat as positive. In others: repeat with a new specimen.
Important: Results are not a standalone diagnosis A GeneXpert result must always be interpreted alongside clinical findings, chest X-ray, TB contact history, and other investigations. A negative result in a child with strong TB symptoms does not completely rule out TB, and clinical judgment remains essential.

Precautions and Safety Points

For Laboratory and Healthcare Staff

  • Always wear gloves when handling patient specimens. Add a lab coat and, where appropriate, eye protection when preparing samples.
  • The sample reagent (SR) contains sodium hydroxide and isopropanol, both of which are corrosive. Avoid skin and eye contact. In case of spills, rinse with water immediately.
  • The sample reagent is tuberculocidal - it kills the TB bacteria. Once the specimen has been mixed with SR and transferred into the cartridge, the risk of TB infection from the sample is greatly reduced. However, standard biosafety precautions should always be maintained.
  • Never open a cartridge once the test has started. The cartridge is a sealed unit; opening it can release aerosols.
  • Dispose of used cartridges as biohazardous waste in accordance with local healthcare waste disposal regulations.
  • Do not attempt to clean the interior of the instrument with liquids.

For Specimen Collection in Children

  • Gastric aspirate must be collected in the early morning, before the child eats or drinks, for best results.
  • Induced sputum collection requires a trained team and appropriate equipment; it should not be attempted without the right setup.
  • Specimens should be stored at 2-8 degrees C and processed as soon as possible. Raw sputum can be stored for up to 8 hours at room temperature or refrigerated for up to 7 days before testing.

Device and Cartridge Handling

  • Cartridges must be stored at 2-28 degrees C. Do not freeze cartridges.
  • The instrument must operate at room temperature between 15 degrees C and 30 degrees C. Operating outside this range increases error rates.
  • The instrument requires a stable, uninterrupted electricity supply. Power cuts during a test will cause errors and wasted cartridges.
  • The instrument modules must be professionally calibrated once a year. Uncalibrated instruments can give inaccurate results.
  • Cartridges must not be reused. Each cartridge is single-use only.
  • Do not use cartridges past their expiry date.
Limitations to know
  • GeneXpert detects rifampicin resistance only, not resistance to other TB drugs (such as isoniazid, ethambutol, pyrazinamide). Full drug susceptibility testing requires culture-based methods.
  • The test cannot distinguish between live and dead TB bacteria. A patient who has recently completed TB treatment may still test positive due to residual DNA from dead bacteria.
  • The sensitivity in children is lower than in adults due to paucibacillary disease. A negative result does not rule out TB in a symptomatic child.

How to Keep the Device and Cartridges Safe

Cartridge Storage

  • Store cartridges at 2-28 degrees C (refrigerator temperature is fine). The manufacturer states cartridges can tolerate up to 45 degrees C for short periods (under 6 weeks at 75% humidity), but routine storage should stay within the recommended range.
  • Store cartridges in their original packaging until ready to use.
  • Do not expose cartridges to direct sunlight or moisture.
  • Check expiry dates before every use and rotate stock using a first-in, first-out system to avoid waste.
  • Cartridges are bulky when boxed. Ensure there is adequate storage space at the facility.

Instrument Care

  • Keep the instrument in a clean, dust-free area. Dust buildup inside modules can affect optical readings.
  • Maintain room temperature between 15-30 degrees C at all times. Air conditioning may be necessary in hot climates.
  • Use a voltage stabilizer or uninterruptible power supply (UPS) to protect against power fluctuations and outages.
  • Clean the exterior of the instrument with a damp cloth. Do not use harsh chemicals or sprays near or inside the instrument.
  • Schedule annual professional calibration of all modules. Keep a log of calibration dates and any error codes.
  • Report any persistent error codes or module failures to a certified Cepheid service technician. Do not attempt to repair internal components.

Software and Data

  • Regularly back up the GeneXpert software database to prevent loss of patient result records.
  • Ensure the computer connected to the instrument has adequate security (password protection, updated antivirus software).
  • Keep the GeneXpert software updated as per manufacturer recommendations.

Frequently Asked Questions (FAQ)

Is the GeneXpert MTB/RIF test safe to use in children?
Yes. The test itself is done on a laboratory specimen - no radiation or invasive procedure is involved in the test itself. The specimen collection method (such as gastric aspirate or induced sputum) may cause mild discomfort but is generally safe when performed by trained staff.
How long does it take to get the result?
Approximately 90 minutes after the cartridge is loaded and the test is started. This is far faster than traditional culture, which takes 2 to 6 weeks.
Can the GeneXpert test replace TB culture?
Not entirely. GeneXpert is excellent for rapid TB detection and rifampicin resistance, but culture remains the gold standard. Culture is still needed to confirm negative GeneXpert results when clinical suspicion is high, and for full drug susceptibility testing beyond rifampicin.
What does a "trace" result in the Ultra version mean for a child?
A "trace" result means TB DNA was detected in a very small amount, near the lowest limit the machine can detect. WHO recommends treating "trace" results as positive in children, people with HIV, and extrapulmonary specimens. This is an important distinction from adults without risk factors, where repeat testing may be done first.
Can the GeneXpert detect all types of drug resistance?
No. The Xpert MTB/RIF test detects rifampicin resistance only. It cannot detect resistance to isoniazid, pyrazinamide, ethambutol, or second-line TB drugs. Full drug susceptibility testing requires liquid or solid culture-based methods.
If a child's GeneXpert result is negative but symptoms persist, what should be done?
Clinical suspicion should not be dismissed based on a negative GeneXpert alone. Repeat testing on a fresh specimen, TB culture, and clinical and radiological evaluation should be pursued. A child with typical TB symptoms, known TB contact, and abnormal chest X-ray may still receive treatment for TB even with a negative GeneXpert.
Can stool be used for the GeneXpert test in children?
Yes, but only with the Xpert MTB/RIF Ultra version, and a specific stool preparation protocol must be followed. Stool is a useful non-invasive specimen option in young children who cannot produce sputum, though its sensitivity is lower than gastric aspirate or induced sputum.
Does a positive GeneXpert result confirm active TB disease?
A positive result confirms the presence of TB bacterial DNA in the sample. This strongly supports active TB but must be interpreted with clinical findings. In rare cases, residual DNA from dead bacteria after completed treatment can give a positive result. Clinical correlation is always required.
Does the GeneXpert test detect latent TB infection?
No. GeneXpert detects TB DNA in specimens from the body, reflecting active TB disease. It cannot detect latent TB infection (where bacteria are dormant). The tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used for latent TB screening.
What causes an INVALID or ERROR result?
Common causes include: an expired or damaged cartridge, insufficient sample volume, substances in the sample that interfere with PCR (called inhibitors), power interruption during the test, or a module calibration issue. When this happens, repeat the test with a fresh cartridge and a new specimen if possible.
Can the GeneXpert diagnose TB outside the lungs (extrapulmonary TB)?
Yes. The system can test cerebrospinal fluid (for TB meningitis), pleural fluid, lymph node aspirates, and tissue biopsies. The Ultra version shows particularly better performance in extrapulmonary samples. Results from non-respiratory specimens should be interpreted carefully as sensitivity may be lower.

Additional Information Relevant to Clinical Use

GeneXpert in HIV-Positive Children

Children with HIV are at high risk of TB and may have atypical disease presentations. The GeneXpert system is particularly valuable in this group because:

  • HIV-positive children often have a higher bacterial load, making the test more sensitive in some scenarios.
  • They are also more likely to have extrapulmonary TB, where GeneXpert (especially Ultra) can test non-sputum specimens.
  • WHO specifically recommends treating "trace" results as positive in HIV-positive individuals, the same as in children.

Role in MDR-TB Identification

Multidrug-resistant TB (MDR-TB) is a serious and growing concern in many parts of the world. The GeneXpert system's ability to detect rifampicin resistance within 90 minutes is a critical tool in quickly identifying children who need specialized MDR-TB management, rather than waiting weeks for culture results. Early identification directly improves treatment outcomes and limits further spread.

GeneXpert as Part of TB Care

GeneXpert is a starting point, not the entire diagnostic process. After a positive result, patients require a full clinical assessment, chest X-ray, treatment planning, and follow-up. A negative result in a strongly suspected case requires further workup. The system is best seen as one important tool within a complete TB care pathway.

WHO End TB Goal The World Health Organization's End TB strategy aims to reduce TB deaths by 90% by 2030. Widespread use of rapid molecular diagnostics like GeneXpert is a central part of this strategy, particularly in high-burden countries where pediatric TB remains a major challenge.

References and Suggested Reading

The following official sources and publications were used in preparing this guide. No hyperlinks are included; search by title or author through your library or medical database:

  • World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Module 3 - Diagnosis. WHO, Geneva. 2021.
  • World Health Organization. Xpert MTB/RIF Implementation Manual. WHO, Geneva. 2014.
  • Cepheid Inc. Xpert MTB/RIF Instructions for Use (Package Insert). Document No. 303-0942.
  • Boehme CC, et al. "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." New England Journal of Medicine. 2010;363:1005-1015.
  • Zar HJ, et al. "Induced Sputum Versus Gastric Lavage for Microbiological Confirmation of Pulmonary Tuberculosis in Infants and Young Children." Lancet. 2005;365(9454):130-134.
  • Graham SM, et al. "Evaluation of Tuberculosis Diagnostics in Children." Journal of Infectious Diseases. 2012;205(S2):S336-S341.
  • Jenkins HE, et al. "Incidence of Multidrug-Resistant Tuberculosis Disease in Children: Systematic Review and Global Estimates." Lancet. 2014;383(9928):1572-1579.
  • Practical considerations - Xpert MTB/RIF Implementation Manual. NCBI Bookshelf. National Library of Medicine.
  • Nelson Textbook of Pediatrics. Kliegman et al. Latest edition. - Tuberculosis chapter.
  • Stegen G, et al. "WHO Policy Statement: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children." WHO, Geneva.
Reviewed by a Pediatrician This content has been checked and reviewed by a qualified pediatrician for medical accuracy.
Medical Disclaimer The information provided on this page is intended for general educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for medical decisions related to tuberculosis testing, diagnosis, or treatment. The GeneXpert MTB/RIF system is a medical device that must be operated by trained laboratory personnel under appropriate clinical supervision. Device specifications, protocols, and WHO recommendations may be updated over time; always refer to the most current manufacturer instructions and guidelines from your national TB program or health authority.

Labels: